Showing 1 - 1 of 1
In the pharmaceutical industry, large-scale research and innovation have been broadly recognized as the major drivers of performance. While this paradigm is still valid, owing to the need to increase firms dimension in order to cope with the high risks related with innovation processes, it would...
Persistent link: https://www.econbiz.de/10011158193